Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis

Digestion

Volumn 70, Issue 4, 2004, Pages 240-249

  Okayama, Mitsuaki ^a   Tsubouchi, Ryoichi ^a   Nishio, Hikaru ^a   Kato, Shinichi ^a   Takeuchi, Koji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Colonic inflammation; Dextran sulfate sodium induced colitis; Enterobacteria; Mucus secretion; Rebamipide; Ulcerative colitis in rats

Indexed keywords

DEXTRAN SULFATE; DRINKING WATER; MESALAZINE; METRONIDAZOLE; MYELOPEROXIDASE; PREDNISOLONE; REBAMIPIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLON; COLON INJURY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; MALE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; ULCER; ULCERATIVE COLITIS; WEIGHT GAIN;

ADMINISTRATION, RECTAL; ALANINE; ANIMALS; ANTI-ULCER AGENTS; ANTICOAGULANTS; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; MALE; QUINOLONES; RATS; RATS, WISTAR;

EID: 17144371877     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083716     Document Type: Article

References (38)

1. Simmonds NJ, Rampton DS: Inflammatory bowel disease - A radical view. Gut 1993;34: 865-868.
2. Suematsu M, Suzuki M, Kitahora T, Miura S, Suzuki K, Hibi T, Watanabe M, Nagata H, Asakura H, Tsuchiya M: Increased respiratory burst of leukocytes in inflammatory bowel: The analysis of free radical generation by using chemiluminescence probe. J Clin Lab Immunol 1987;24:125-128.
3. Shiratora Y, Aoki S, Takada H, Kiriyama H, Ohto K, Hai K, Teraoka H, Matano S, Matsumoto K, Kamii K: Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 1989;44:163-171.
4. Hirata I, Murano M, Nitta M, Sasaki S, Toshina K, Maemura K, Katsu K: Estimation of mucosal inflammatory mediators in rat DSS-induced colitis. Digestion 2001;63:73-80.
5. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-1350.
6. Uchida M, Tabusa F, Komatsu M, Morita S, Kanbe T, Nakagawa K: Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. Synthesis and antiulcer activities of optically active α-amino acid derivatives of 2(1H)-quinolinone and oxindole. Chem Pharm Bull (Tokyo) 1987;35:853-856.
7. Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S: Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol 1987;142:23-29.
8. Yamasaki K, Ishiyama H, Imaizumi T, Kanbe T, Yabuuchi Y: Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Jpn J Pharmacol 1989;49:441-448.
9. Murakami K, Okajima K, Harada N, Isobe H, Okabe H: Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats. Dig Dis Sci 1998;43:139S-142S.
10. Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S: Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 1992;212:9-13.
11. Yoshikawa T, Naito Y, Tanigawa T, Kondo M: Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung 1993; 43:363-366.
12. Hahm KB, Park IS, Kim YS, Kim JH, Cho SW, Lee SI, Youn JK: Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells. Free Radic Biol Med 1997;22:711-716.
13. Ishihara K, Komuro Y, Nishiyama N, Yamasaki K, Hotta K: Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung 1992;42:1462-1466.
14. Mizoguchi H, Ogawa Y, Kanatsu K, Tanaka A, Kato S, Takeuchi K: Protective effect of rebamipide on indomethacin-induced intestinal damage in rats. J Gastroenterol Hepatol 2001;16: 1112-1119.
15. Kishimoto S, Haruma K, Tari A, Sakurai K, Nakano M, Nakagawa Y: Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats. Dig Dis Sci 2000;45:1608-1616.
16. Iwai A, Iwashita E: Changes in colonic inflammation induced by dextran sulfate sodium during short- and long-term administration of rebamipide. Dig Dis Sci 1998;43:143S-147S.
17. Makiyama K, Takeshima F, Kawasaki H, Zea-Iriarte WL: Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: A novel therapeutic alternative. Am J Gastroenterol 2000;95:1838-1839.
18. Cooper HS, Murthy SNS, Shah RS, Sedergran DJ: Clinicopathological study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-249.
19. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
20. Azumi Y, Ohara S, Ishihara K, Okabe H, Hotta K: Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut 1981;21: 533-536.
21. 2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci 2002;47:894-904.
22. Rath HC, Ikeda JS, Linde HJ, Scholmerich J, Wilson KH, Sartor RB: Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 1999; 116:310-319.
23. Ogawa Y, Kanatsu K, Iino T, Kato S, Jeong YI, Shibata N, Takata K, Takeuchi K: Protection against dextran sulfate sodium-induced colitis by microspheres of ellagic acid in rats. Life Sci 2002;71:827-839.
24. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992;26:48-57.
25. Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T: The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice. Eur J Pharmacol 2001;12:91-99.
26. Rachimilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo JV, Xavier RJ, Podolsky DK: Peroxynitrite-induced rat colitis - A new model of colonic inflammation. Gastroenterology 1993;105:1681-1688.
27. Nagano C, Wakebe H, Azuma A, Imagawa K, Kikuchi M: IFN-γ-induced iNOS mRNA expression is inhibited by rebamipide in murine macrophage RAW264.7 cells. Dig Dis Sci 1998;43:118S-124S.
28. 2 receptor subtype with rat dextran sodium sulphate colitis: Colitis suppression by a selective agonist, ONO-AE1-329. Scand J Immunol 2002;56:66-75.
29. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, Narumiya S: The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002;109: 883-893.
30. Okayama M, Tsubouchi R, Rumi G, Kato S, Takeuchi K: Aggravation by selective cyclooxygenase-2 inhibitor of dextran sulfate sodium-induced colonie lesions in rats (abstract). Gastroenterology 2004;126:A583.
31. 2 and EP receptor subtypes; in Cho CH, Wang JY (eds): Gastrointestinal Mucosal Repair and Experimental Therapeutics. Basel, Karger, 2002, pp 227-242.
32. Aihara M, Imagawa K, Funakoshi Y, Ohmoto Y, Kikuchi M: Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells. Dig Dis Sci 1998; 43(suppl):160-166.
33. Kato S, Tanaka A, Kunikata T, Umeda M, Takeuchi K: Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: Relation to capsaicin-sensitive sensory neurons. Digestion 2000;61:39-46.
34. 2-receptor antagonist, on dextran sulfate sodium-induced colonic inflammation through capsaicin-sensitive afferent neurons in rats. Dig Dis Sci 2004;49:1696-1704.
35. Ishihara K, Komuro Y, Nishiyama N, Yamasaki K, Hotta K: Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung 1992;42:1462-1466.
36. Suetugu H, Ishihara S, Moriyama N, Kazumori H, Adachi K, Fukuda R, Watanabe M, Kinoshita Y: Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa. J Lab Clin Med 2000;136:50-57.
37. Tanaka A, Mizoguchi H, Kunikata T, Miyazawa T, Takeuchi K: Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats. J Physiol Paris 2001;95:35-41.
38. 2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci 2002;47:894-904.